CARDIAC AUTONOMIC DYSFUNCTION IN PATIENTS WITH EPILEPSY

Authors

  • RASHMI H. Bangalore Medical College and Research Institute, Bengaluru-560002, Karnataka, India https://orcid.org/0009-0006-9631-4080
  • PRAVEEN PANCHAKSHARIMATH Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru-560002, Karnataka, India https://orcid.org/0000-0002-6973-9482
  • ROHITH V. Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru-560002, Karnataka, India https://orcid.org/0009-0000-0702-2171

DOI:

https://doi.org/10.22159/ijpps.2023v15i10.49095

Keywords:

Autonomic function tests, Heart rate variability, Epilepsy, SUDEP

Abstract

Objective: The objective of this research was to appraise autonomic impairment through the examination of both time-domain and frequency-domain parameters of heart rate variability in individuals with epilepsy.

Methods: Thirty epilepsy patients and thirty healthy subjects were enrolled in our study for evaluation of autonomic functions, which was assessed by comparing heart rate variability between epilepsy patients and healthy subjects.

Results: There was no notable disparity observed in mean heart rate between the two groups. However, the frequency-domain metrics-LF Power, HF Power, and LF/HF ratio exhibited statistically noteworthy differences when comparing the patients to the control group (p-value<0.05). Conversely, parameters such as SDNN, RMSST, and pNN50 did not demonstrate statistically considerable differences in comparison to the controls (p-value>0.05). The parameters did not exhibit statistically significant distinctions between individuals with epilepsy for under 10 y and those diagnosed with epilepsy for over 10 y.

Conclusion: Our investigation revealed a notable contrast in HRV metrics between the patient group and the group of individuals in good health. The potential utilization of HRV as an indicator of susceptibility to SUDEP could enhance the quality of guidance provided to both patients and their families. Additional exploration is warranted, involving more extensive participant cohorts, and examining the impact of antiepileptic medications on HRV, within future studies.

Downloads

Download data is not yet available.

References

Stafstrom CE, Carmant L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med. 2015;5(6)Suppl 6. doi: 10.1101/cshperspect.a022426, PMID 26033084.

World Health Organization. Epilepsy. Fact sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy. [Last accessed on 10 Feb 2023]

Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia. 1997;38 Suppl 1:S1-8. doi: 10.1111/j.1528-1157.1997.tb04511.x, PMID 9092951.

Ansakorpi H, Korpelainen JT, Suominen K, Tolonen U, Myllylä VV, Isojärvi JI. Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy. Epilepsia. 2000;41(1) Suppl 1:42-7. doi: 10.1111/j.1528-1157.2000.tb01503.x, PMID 10643922.

Ravindran K, Powell KL, Todaro M, O’Brien TJ. The pathophysiology of cardiac dysfunction in epilepsy. Epilepsy Res. 2016;127:19-29. doi: 10.1016/j.eplepsyres.2016.08.007, PMID 27544485.

Urooj M, Gupta S, Venkateshan SP, Tandon M. Reference range of heart rate variability and validation in subjects with asymptomatic elevated liver function enzymes. Int J Curr Pharm Res. 2014;6Suppl 4:49-52.

Lathers CM, Schraeder PL, Weiner FL. Synchronization of cardiac autonomic neural discharge with epileptogenic activity: the lockstep phenomenon. Electroencephalogr Clin Neurophysiol. 1987;67(3) Suppl 3:247-59. doi: 10.1016/0013-4694(87)90023-x, PMID 2441959.

Drake ME Jr, Andrews JM, Castleberry CM. Electrophysiologic assessment of autonomic function in epilepsy. Seizure. 1998;7(2):91-6. doi: 10.1016/S1059-1311(98)80062-9, PMID 9627197.

Malik M. Clinical guide to cardiac autonomic tests. Dordrecht: Kluwer Academic Publishers; 1998.

Phurpa FS. Evaluation of autonomic dysfunction by heart rate variability analysis in type 2 diabetes mellitus. Asian J Pharm Clin Res. 2017;10 Suppl 1:309-12.

You SM, Jo HJ, Cho BH, Song JY, Kim DY, Hwang YH. Comparing ictal cardiac autonomic changes in patients with frontal lobe epilepsy and temporal lobe epilepsy by ultra-short-term heart rate variability analysis. Medicina (Kaunas). 2021;57(7):666. doi: 10.3390/medicina57070666, PMID 34203291.

Adebiyi AM, Komolafe MA, Idowu AO, Omon HE, Ogunniyi A. Cardiac autonomic neuropathy in adult epilepsy patients in a tertiary hospital in South-Western Nigeria. Niger J Clin Pract. 2020;23(10) Suppl 10:1437-42. doi: 10.4103/njcp.njcp_73_20, PMID 33047703.

Ramaekers D, Ector H, Aubert AE, Rubens A, Van de Werf F. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J. 1998;19(9) Suppl 9:1334-41. doi: 10.1053/euhj.1998.1084, PMID 9792258.

Tomson T, Ericson M, Ihrman C, Lindblad LE. Heart rate variability in patients with epilepsy. Epilepsy Res. 1998;30(1):77-83. doi: 10.1016/s0920-1211(97)00094-6, PMID 9551847.

Taylor JA, Lipsitz LA. Heart rate variability standards. Circulation. 1997;95(1) Suppl 1:280-1, PMID 8994452.

Mativo P, Anjum J, Pradhan C, Sathyaprabha TN, Raju TR, Satishchandra P. Study of cardiac autonomic function in drug-naïve, newly diagnosed epilepsy patients. Epileptic Disord. 2010;12(3) Suppl 3:212-6. doi: 10.1684/epd.2010.0325, PMID 20647166.

Massetani R, Strata G, Galli R, Gori S, Gneri C, Limbruno U. Alteration of cardiac function in patients with temporal lobe epilepsy: different roles of EEG‐ECG monitoring and spectral analysis of RR variability. Epilepsia. 1997;38(3):363-9. doi: 10.1111/j.1528-1157.1997.tb01129.x, PMID 9070600.

Meghana A, Sathyaprabha TN, Sinha S, Satishchandra P. Cardiac autonomic dysfunction in drug-naive hot water epilepsy. Seizure. 2012;21(9):706-10. doi: 10.1016/j.seizure.2012.07.014, PMID 22898675.

Persson H, Ericson M, Tomson T. Heart rate variability in patients with untreated epilepsy. Seizure. 2007;16(6) Suppl 6:504-8. doi: 10.1016/j.seizure.2007.03.010, PMID 17493840.

DeGiorgio CM, Miller P, Meymandi S, Chin A, Epps J, Gordon S. RMSSD, A measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav. 2010;19(1) Suppl 1:78-81. doi: 10.1016/j.yebeh.2010.06.011, PMID 20667792.

Nashef L, Walker F, Allen P, Sander JW, Shorvon SD, Fish DR. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry. 1996;60(3) Suppl 3:297-300. doi: 10.1136/jnnp.60.3.297, PMID 8609507.

Myers KA, Bello Espinosa LE, Symonds JD, Zuberi SM, Clegg R, Sadleir LG. Heart rate variability in epilepsy: a potential biomarker of sudden unexpected death in epilepsy risk. Epilepsia. 2018;59(7) Suppl 7:1372-80. doi: 10.1111/epi.14438, PMID 29873813.

Published

01-10-2023

How to Cite

H., R., P. PANCHAKSHARIMATH, and R. V. “CARDIAC AUTONOMIC DYSFUNCTION IN PATIENTS WITH EPILEPSY”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 10, Oct. 2023, pp. 13-16, doi:10.22159/ijpps.2023v15i10.49095.

Issue

Section

Original Article(s)